Early IS Good is classified as operating in the N/A industry, NAICS Code .
Investor Activity
Early IS Good has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
November 9, 2022
1
37%
$4 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Early IS Good is developing and marketing.
Early IS Good doesn't have any recent trademark applications, indicating Early IS Good is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
EARLY IS GOOD diagnostic test kits comprised of medical diagnostic reagents, assays, and biomarkers for testing bodily fluids for use in disease detection, namely, for cancer diagnostics and personalized medicine
03/27/2021
See all trademarks and details in the Full Report.
Nearby Competitors
These companies are similar in business line and location to Early IS Good.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Early IS Good's Fastest Growing Competitors
These companies are in the same general field as Early IS Good and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.